A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Clinical trial NCT01128894 · COMPLETED

Trial details

NCT number: NCT01128894
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-05-01
Primary completion: 2011-09-01
Enrollment: 841

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.